about
Autoantibody-associated kappa light chain variable region gene expressed in chronic lymphocytic leukemia with little or no somatic mutation. Implications for etiology and immunotherapyMolecular characterization of the variable domains of an alphaIIbbeta3-specific immunoglobulin M kappa platelet cold agglutinin in a follicular lymphoma patient with treatment refractory autoimmune thrombocytopenia: idiotypic overlap between alphaIIMalignant B cells and antigenic receptor: necessity or habit?The molecular genetics of hematologic malignanciesImmunoglobulin V gene expression in CD5 B-cell malignancies.Characterization of the immunoglobulin heavy chain complementarity determining region (CDR)-III sequences from human B cell precursor acute lymphoblastic leukemia cells.A human lymphoma cell line with multiple immunoglobulin rearrangements.Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of developmentThe cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entryFunctional immunoglobulin light chain genes are replaced by ongoing rearrangements of germline V kappa genes to downstream J kappa segment in a murine B cell line.Clonal evolution of a follicular lymphoma: evidence for antigen selection.Regulatory influences of neonatal multispecific antibodies on the developing B cell repertoire.Antibody specificity of the human monoclonal immunoglobulins: the elusive target antigen.Development of a new therapeutic approach to B cell malignancy. The induction of immunity by the host against cell surface receptor on the tumor.Differential usage of an autoantibody-associated VH gene, VH4-21, by human B-cell tumors.Activation-induced cytidine deaminase expression in follicular lymphoma: association between AID expression and ongoing mutation in FL.The clonogenic precursor cell in multiple myeloma.Somatic hypermutations in the immunoglobulin genes of two new human lymphoma lines of lymphatic follicle origin.Molecular characterization of an unusual non-Hodgkin's B-lymphoma cell line ("Farage") lacking the ability to produce immunoglobulin polypeptide chains.The somatic hypermutation activity of a follicular lymphoma links to large insertions and deletions of immunoglobulin genes.Limitations of clonality analysis of B cell proliferations using CDR3 polymerase chain reaction.Burkitt's lymphomas express VH genes with a moderate number of antigen-selected somatic mutations.Structural analysis of VH4-21 encoded human IgM allo- and autoantibodies against red blood cells.Alterations in immunoglobulin genes reveal the origin and evolution of monotypic and bitypic B cell lymphomas.Immunoglobulin Gene Rearrangement and Expression in B-CLL.Alterations of the immunoglobulin heavy chain locus in progressive B-cell lymphomas.New type of t(14;18) in a non-Hodgkin's lymphoma provides insight in molecular events in early B-cell differentiation.Clonal history of a human follicular lymphoma as revealed in the immunoglobulin variable region genes.Clonal selection in the bone marrow involvement of follicular lymphoma.
P2860
Q24296490-E27D89F4-E6B1-43C8-AB12-A11D08FE11F9Q33275315-48EB1DFF-84C9-4458-A5C5-6B114CBE0DDDQ34975532-1775D852-BD67-4CAD-BE21-5153FB9E7D67Q35224361-DA19F8AB-0843-476C-90D7-92B3FAC9AA5DQ35320881-7A9E52E7-E37F-4D09-B7EA-5AC7C8E296E4Q35598751-AAE77A70-680D-46E3-BC15-2DAF7A893511Q35599761-66875817-EAC8-4175-B4D9-74379E065A38Q35888216-2CC4DDB4-C29C-4ABA-B93D-1D5D9A74D662Q35917268-4D7F8757-C74E-4222-BD76-ACC9F8BAD208Q36356576-2E467E82-4A84-40C5-8F0D-D40C021C4EC9Q37120876-4AE3C9F3-193B-44A9-87BC-47A4CB4356ABQ38201771-D878F9BD-0EC0-4FF7-B2E2-53B39EB65C35Q38219282-4C6866A4-A1BB-420A-8A6B-E8116F635E18Q38246919-E6850B94-D871-4882-B6CB-E7C725F5C991Q40548683-182908CF-6F01-4A84-899F-ADDFCA5A0336Q40584407-2A5C3196-B8A0-4CBF-B803-D053620E77D2Q40931206-FC04CB6A-9553-400C-9B00-4A23CECF974FQ41040876-51B7E366-F800-4E8A-854C-BEE275F43C56Q41200046-B3BD35CD-08BC-4E1E-82F8-46BA3728F9E2Q41329806-E69C4A83-834C-49BA-BAE5-3885D1E1504BQ41786536-8F6D4EA2-7283-451A-B159-BD91304F96E6Q41828070-634FA3B0-0A12-4DD1-BED6-0C736EDEFE4BQ42680115-C3B0A8CC-3AB6-4710-B19B-87FD1CAAA150Q42769380-B21AD1A7-2FE9-4838-BEFA-F32B2C2F9E40Q46102109-E66E8CFC-F300-422F-9CF7-BADFB74BB360Q47943322-31FFB508-60E2-416C-83A4-4D10CF93B9ACQ48069502-ED760E03-AF00-4307-AE84-917513719ED4Q48084578-D991537B-5556-40E1-99CA-65525FD28807Q54657499-3FF717B4-9602-4D85-880A-9A2FF3CFD7CE
P2860
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Somatic mutation in human B-cell tumors.
@en
Somatic mutation in human B-cell tumors.
@nl
type
label
Somatic mutation in human B-cell tumors.
@en
Somatic mutation in human B-cell tumors.
@nl
prefLabel
Somatic mutation in human B-cell tumors.
@en
Somatic mutation in human B-cell tumors.
@nl
P2093
P2860
P1476
Somatic mutation in human B-cell tumors.
@en
P2093
P2860
P356
10.1111/J.1600-065X.1987.TB00508.X
P577
1987-04-01T00:00:00Z